Huadong Medicine Co., Ltd
000963
Classificação em ações
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Preço da ação
$3.89
Valor de mercado
$6.83B
Variação (1 dia)
-2.22%
Variação (1 ano)
-30.58%
País
CN
Negociar Huadong Medicine Co., Ltd (000963)
Categoria
Healthcare
Rácio P/B de Huadong Medicine Co., Ltd (000963)
Rácio P/B em October 2026 TTM: 1.79
De acordo com os relatórios financeiros mais recentes e o preço das ações da Huadong Medicine Co., Ltd, o rácio P/B atual (TTM) é 1.79. No final de 2024, o rácio P/B era 2.63.
Histórico do rácio P/B da Huadong Medicine Co., Ltd de 2001 a 2026
Rácio P/B no final de cada ano
| Ano | Rácio P/B | Alterar |
|---|---|---|
| 2026 (TTM) | 1.79 | -35.76% |
| 2025 | 2.79 | 5.99% |
| 2024 | 2.63 | -23.81% |
| 2023 | 3.45 | -21.72% |
| 2022 | 4.41 | 3.89% |
| 2021 | 4.24 | 33.47% |
| 2020 | 3.18 | -8.27% |
| 2019 | 3.47 | -1.23% |
| 2018 | 3.51 | -44.06% |
| 2017 | 6.27 | 31.37% |
| 2016 | 4.77 | -60.08% |
| 2015 | 11.96 | 18.56% |
| 2014 | 10.09 | 29.56% |
| 2013 | 7.79 | 5.26% |
| 2012 | 7.40 | -1.93% |
| 2011 | 7.54 | -38.83% |
| 2010 | 12.33 | 73.78% |
| 2009 | 7.10 | 14.69% |
| 2008 | 6.19 | -52.76% |
| 2007 | 13.10 | 341.31% |
| 2006 | 2.97 | 36.69% |
| 2005 | 2.17 | -9.09% |
| 2004 | 2.39 | -0.72% |
| 2003 | 2.41 | -4.52% |
| 2002 | 2.52 | -3.19% |
| 2001 | 2.60 | 0.00% |
Rácio P/B de empresas semelhantes ou concorrentes
| Empresa | Rácio P/B | Diferença do rácio P/B | País |
|---|---|---|---|
| 1.9834 | 10.67% |
DE
|
|
| 2.1139 | 17.95% |
DE
|
|
| 1.3124 | -26.77% |
JP
|
|
| 6.3468 | 254.13% |
CH
|
|
| 5.0287 | 180.59% |
IN
|
